Skip to content

Does Vnotes Salpingectomy Reduce Ovarian Reserve?

Does Vnotes Salpingectomy Reduce Ovarian Reserve?

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07177144
Enrollment
46
Registered
2025-09-16
Start date
2025-06-19
Completion date
2025-11-17
Last updated
2025-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Reserve, Salpingectomy, Vnotes

Keywords

vnotes, salpingectomy, ovarian reserve

Brief summary

Comparison of Transvaginal Natural Orifice Transluminal Endoscopic Surgery and Conventional Laparoscopy in terms of their effects on ovarian reserve in Opportunistic Bilateral Salpingectomy for Permanent Female Sterilization

Detailed description

The study will include participants who apply to our clinic for salpingectomy for contraception and agree to participate in the study. vnotes salpingectomy method or classical laparoscopic salpingectomy will be offered to the patients as two salpingectomy methods and the patient will be included in whichever group in the study. All surgeries will be performed by the same surgeon. 3 months after the date of surgery, the patient will be called for a follow-up for amh repeat and the two groups will be compared both within themselves and with each other to evaluate whether the different surgical technique has an effect on ovarian reserve.

Interventions

OTHERanti müllerian hormone

participants were checked for amh levels preoperatively

DIAGNOSTIC_TESTanti müllerian hormon

participants were checked for amh levels at 3 months postoperatively.

Sponsors

Gaziosmanpasa Research and Education Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* to want to have your tubes removed, not to have undergone tubal and ovarian surgery before, not to use hormones and medications that can affect the level of sex hormones and its levels,

Exclusion criteria

* not being in the specified age range (18-45), having a history of tubal ligation, having tubal cancer

Design outcomes

Primary

MeasureTime frameDescription
measuring anti-millerian hormone levelamh level (ng/ml) will be checked before the operation, and after 3 months, she will be called for control and measured again.To evaluate the effect of two surgical methods on ovarian reserve by measuring serum anti-Müllerian hormone levels (ng/ml) before surgery and after salpingectomy.

Secondary

MeasureTime frameDescription
comparison of duration of surgeryPerioperativeTo compare the success of the two surgical techniques Surgery duration: the time from when the patient first receives anesthesia until they are awakened, recorded in minutes (min)
Postoperative hospital stay durationPerioperativeThe days the patient stays in the hospital, starting from the first day they are admitted for surgery until they are discharged after full recovery following the surgery, will be recorded as days. the number of days the patient stays in the hospital, recorded in days (days)
postoperative painfirst hour after surgeryThe patient is asked to rate the pain they feel from the moment they wake up after surgery on a scale of 1 to 10.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026